De Villez R L, Dunn J
Arch Dermatol. 1986 Sep;122(9):1011-5. doi: 10.1001/archderm.122.9.1011.
Twenty-five women fulfilling the criteria for female alopecia, of either the male pattern baldness type or female pattern baldness type, were evaluated for hormone markers to delineate the clinical baldness patterns. Women with a marked increase in the 3 alpha,17 beta-androstanediol glucuronide/sex hormone binding globulin ratio and low serum sex hormone binding globulin were noted to have female pattern baldness. This pattern of baldness may represent hair loss from the influence of minimal androgen excess on genetically sensitive hair bulbs in the absence of other signs of maximal androgen excess, including hirsutism, acne, or virilism.
对25名符合男性型秃发或女性型秃发标准的女性进行了激素指标评估，以明确临床秃发模式。3α,17β -雄甾二醇葡萄糖醛酸苷/性激素结合球蛋白比值显著升高且血清性激素结合球蛋白水平较低的女性被认为患有女性型秃发。这种秃发模式可能代表在没有多毛症、痤疮或男性化等其他雄激素过多的明显体征的情况下，最低限度雄激素过多对遗传敏感毛囊产生影响而导致的脱发。
